NR1H4 and metabolic dysfunction-associated steatohepatitis: Studies indicate that signals mediated by bile acid farnesoid X receptor (FXR), including the enterohepatic hormone fibroblast growth factor 15/19, play a role in regulating glucose and TG metabolism in NASH [11].